Metastatic head and neck cancer
Clinical trials for Metastatic head and neck cancer explained in plain language.
Never miss a new study
Get alerted when new Metastatic head and neck cancer trials appear
Sign up with your email to follow new studies for Metastatic head and neck cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 'seek and destroy' therapy for metastatic cancer enters human testing
Disease control Recruiting nowThis early-stage study tests a two-part system to find and treat metastatic cancer. First, a radioactive tracer is used to spot tumors on a PET scan. Then, a similar radioactive drug is given to deliver radiation directly to the cancer cells. The goal is to see if this approach i…
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase 1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New triple-drug cocktail takes on hard-to-treat head and neck cancer
Disease control Recruiting nowThis phase 2 trial is testing a combination of three therapies—modified immune cells (PD-L1 t-haNK), an immune-boosting protein (NAI/Anktiva), and a targeted antibody (cetuximab)—in 25 people with recurrent or metastatic head and neck cancer that has not responded to prior immuno…
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Ultrasound boosts cancer drug in tiny trial
Disease control Recruiting nowThis early study tests whether using ultrasound and microbubbles can help the immunotherapy drug pembrolizumab (Keytruda) work better in people with head and neck cancer that has come back or spread. Only 6 participants will receive three rounds of treatment. The main goal is to …
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase 1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Morning or afternoon? new study tests if immunotherapy timing boosts cancer fight
Knowledge-focused Recruiting nowThis study looks at whether getting immunotherapy infusions in the morning versus the afternoon changes outcomes for people with advanced lung cancer or head and neck cancer. About 238 participants will be randomly assigned to morning or afternoon infusions. Researchers will trac…
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC